Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA in Pulmonary Arterial Hypertension
NCT03648385Phase 2Completed
- Sponsor
- Rhode Island Hospital
- Start
- Jan 2019
- Primary completion
- Jun 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of dehydroepiandrosterone in pulmonary arterial hypertension (PAH), sponsored by Rhode Island Hospital. Started Jan 2019; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03648385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03648385.